Dr Lal Pathlabs Ltd (LALPATHLAB) — Corporate Action | 24 September 2026
Dr Lal Pathlabs announced acquisition of 70% stake in SN Genelab Private Limited for up to INR 168 crores cash plus INR 31.5 crores performance-linked earnout, targeting November 30, 2026 completion to expand genomics capabilities.
About Dr Lal Pathlabs Ltd (LALPATHLAB)
Healthcare · Healthcare · Listed on BSE
📡 Get AI alerts when LALPATHLAB files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track LALPATHLAB — Free💡 Ask AI about this filing
📊 More LALPATHLAB filings
- 🔴 Corporate Action — 1 October 2026Dr Lal Pathlabs announced completion of its acquisition of SN Genelab Private Limited on October 1, ...
- 🔴 Corporate Action — 26 September 2026Dr Lal PathLabs announced completion of its Dubai subsidiary's acquisition of an 80% stake in Sunshi...
- 🟡 Board Meeting — 25 September 2026The board announced a meeting on November 4, 2026 to approve unaudited standalone and consolidated f...
- Announcement — 25 September 2026Dr Lal Pathlabs announced a board meeting on November 4, 2026, to approve Q3 and H1 FY27 financial r...
- 🔴 Corporate Action — 27 August 2026Dr Lal Pathlabs announced completion of its 30% stake acquisition in Neuome Technologies Private Lim...
🔥 Also filed on 24 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when LALPATHLAB files new disclosures
Track LALPATHLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track LALPATHLAB — FreeFree account · 2 AI queries/day